The sprint to create a COVID-19 vaccine started in January. The finish line awaits.

For five days, the FedEx plane sat on the tarmac in Shanghai. American scientists at Novavax, a biotech company in suburban Maryland, waited with increasing impatience. The plane held a copy of a key gene from the newly discovered coronavirus. Novavax needed the gene to try to develop a vaccine. The scientists had been in similar situations before. Every time a new disease came along – SARS, MERS, Ebola – they made candidate vaccines to see whether they could tame it. They thought of their research as an experiment. But the longer the plane remained stuck, the more they wondered if this time might not be a drill. By Jan. 30, the fourth day, the virus still lacked a name, but it already was i

Donald Trump's COVID-19 treatment is similar to the average American hospitalized with coronavirus.

President Donald Trump has had the best possible care for his COVID-19, his doctors have repeatedly assured America. "He's on a routine regimen of COVID therapy," his physician Sean Conley said Monday. It's true that while he's had outstanding care, Trump's therapies have been similar to those available to most other hospitalized COVID-19 patients – with two major exceptions. The president received a dose of an experimental drug only tried so far in about 2,000 people as part of a research trial, and he's gotten everything far sooner than would a typical COVID-19 patient. Read the rest of the story on USATODAY.com Photo: President Donald J. Trump works in the Presidential Suite at Walter Ree

About me

Cover COVID-19 

and patient safety

for USA Today.

Former long-time health/science

journalist, contributing to The

New York Times, The Washington Post, 

Scientific American.com, and others. Journalism educator and book author.

Contact:

kweintraub@usatoday.com

  • Twitter Social Icon
Recent Posts
Archive
Search By Tags
No tags yet.